About Illinois Eye Center
At Illinois Eye Center, we continually strive to protect and preserve visual health in our community, by providing patient-centered access to the most comprehensive multi-specialty team, integrated diagnostics, and advanced therapeutic technologies.
We are committed to our patients by providing same day access for acute/urgent eye conditions or for routine vision exams through our exclusive EyeCareToday service.
Our supportive environment is created by truly listening to our patients, encouraging personal and professional growth in our colleagues, and striving to improve the communities where we live and work.
Meet our Providers
Illinois Eye Center doctors are proud to be involved in clinical research studies. Our mission is to advance the science of medicine. Our dedicated medical professionals respect our research participants and pride themselves on providing accurate information. We have participated in many studies over the years and are currently enrolling patients in studies. We are proud to partner with sponsor companies to lead the way in the future of medicine. All patients who participate in clinical trials are compensated for their time and travel.
What is a Clinical Trial?
The purpose of clinical trials is to give medical knowledge and research to help treat, diagnose, and possibly prevent a condition. Clinical research involves using human volunteers, and each clinical trial has a list of inclusion and exclusion criteria. Our providers will perform a history and exam to determine if you are a candidate for one of our clinical trials.
Open and Enrolling Trials:
Travoprost Intraocular Implant
If you’ve been told by your doctor that you have glaucoma or high eye pressure, you may be able to participate in a clinical study of the Travoprost Intraocular Implant. To qualify, you must be 35 years of age or older and meet all other study-related criteria. For more information, visit: http://www.GlaukosClinicalTrials.com.
NICOX – 470
Do you have glaucoma or high eye pressure?
If so, you may qualify for a new investigational eye drop research study!
If you have previously been diagnosed with glaucoma or increased eye pressure and are at least 18 years of age, we invite you to participate.
The study involves about 12 office visits over the course of approximately 12 months.
GATHER2 is a phase 3 trial testing a potential treatment known as Zimura® (avacincaptad pegol).
A phase 3 trial is the final phase of testing typically required for a treatment to be approved by the US Food and Drug Administration (FDA). The trial doctors want to find out if Zimura® can help slow down the progression of geographic atrophy (GA). The trial doctors will also evaluate potential side effects of Zimura®.
What is Geographic atrophy (GA)?
Geographic atrophy, or GA, is an advanced form of AMD. It affects the macula, which is responsible for your central vision. Individuals with dry AMD or wet AMD can develop GA. GA often affects both eyes. There is no US Food and Drug Administration (FDA)–approved treatment for GA. As GA progresses, you may experience blind spots, distortions, or other changes to your vision. For more information, visit: GATHER2Trial.com
Read our Blog
Stay up-to-date on everything from LASIK to general eye care.